世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の医療大麻市場 2018-2022年

Global Medical Marijuana Market 2018-2022

 

出版社 出版年月電子版価格 ページ数
TechNavio
テクナビオ
2018年3月US$2,500
シングルユーザライセンス
115

サマリー

このレポートは世界の医療大麻市場を調査したTechNavioの調査報告書です。

Report Details

This market research report presents a comprehensive analysis of the global medical marijuana market by application such as chronic pain, nausea, and others. The report also presents a detailed analysis of the market’s growth prospects across regions such as the Americas, APAC, and EMEA.
Our market research analysts have predicted that the medical marijuana market will grow at a CAGR of more than 21% by 2022.
Segmentation by application and analysis of the medical marijuana market
-Chronic pain
-Nausea
The chronic pain segment accounted for the majority shares of the medical cannabis market during 2017. With the rising application of medical marijuana for the treatment of patients with chronic pain, this segment will continue to account for the maximum growth of this market in the coming years as well.
Segmentation by geography and analysis of the medical marijuana market
-Americas
-APAC
-EMEA
In terms of geographic regions, the Americas contributed to the maximum growth of the medical cannabis market. Owing to the growing consumption of medical marijuana, the region will offer the maximum growth opportunities to the companies in this medical marijuana market during the next four years.
Key questions answered in the report include
- What will the market size and the growth rate be in 2022?
- What are the key factors driving the global medical marijuana market?
- What are the key market trends impacting the growth of the global medical marijuana market?
- What are the challenges to market growth?
- Who are the key vendors in the global medical marijuana market?
- What are the market opportunities and threats faced by the vendors in the global medical marijuana market?
- What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
- What are the key outcomes of the five forces analysis of the global medical marijuana market?


目次

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY APPLICATION
- Segmentation by application
- Comparison by application
- Global medical marijuana market by chronic pain
- Global medical marijuana market by nausea
- Global medical marijuana market by others
- Market opportunity by application
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Medical marijuana market in Americas
- Medical marijuana market in EMEA
- Medical marijuana market in APAC
- Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
- Emergence of luxury cannabis products
- Increased public and private funding in cannabis industry
- Increasing promotional activities
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Aurora Cannabis
- GW Pharmaceuticals
- mCig
- Medical Marijuana
- United Cannabis
- Other prominent vendors
PART 15: APPENDIX
- List of abbreviation

Exhibit 01:Parent market
Exhibit 02:Global legal cannabis market
Exhibit 03:Market characteristics
Exhibit 04:Market segments
Exhibit 05:Market definition - Inclusions and exclusions checklist
Exhibit 06:Market size 2017
Exhibit 07:Validation techniques employed for market sizing 2017
Exhibit 08:Global medical marijuana market - Market size and forecast 2017-2022 ($ bn)
Exhibit 09:Global medical marijuana market - Year over year growth 2018-2022 (%)
Exhibit 10:Five forces analysis 2017
Exhibit 11:Five forces analysis 2022
Exhibit 12:Bargaining power of buyers
Exhibit 13:Bargaining power of suppliers
Exhibit 14:Threat of new entrants
Exhibit 15:Threat of substitutes
Exhibit 16:Threat of rivalry
Exhibit 17:Market condition - Five forces 2022
Exhibit 18:Global medical marijuana market by application - Market share 2017-2022 (%)
Exhibit 19:Comparison by application
Exhibit 20:Global medical marijuana market by chronic pain - Market size and forecast 2017-2022 ($ bn)
Exhibit 21:Global medical marijuana market by chronic pain - Year over year growth 2018-2022 (%)
Exhibit 22:Global medical marijuana market by nausea - Market size and forecast 2017-2022 ($ bn)
Exhibit 23:Global medical marijuana market by nausea - Year over year growth 2018-2022 (%)
Exhibit 24:Global medical marijuana market by others - Market size and forecast 2017-2022 ($ bn)
Exhibit 25:Global medical marijuana market by others - Year over year growth 2018-2022 (%)
Exhibit 26:Market opportunity by application
Exhibit 27:Customer landscape
Exhibit 28:Global medical marijuana market by region - Market share 2017-2022 (%)
Exhibit 29:Regional comparison
Exhibit 30:Medical marijuana market in Americas - Market size and forecast 2017-2022 ($ bn)
Exhibit 31:Medical marijuana market in Americas - Year over year growth 2018-2022 (%)
Exhibit 32:Top three countries in Americas
Exhibit 33:Medical marijuana market in EMEA - Market size and forecast 2017-2022 ($ bn)
Exhibit 34:Medical marijuana market in EMEA - Year over year growth 2018-2022 (%)
Exhibit 35:Top three countries in EMEA
Exhibit 36:Medical marijuana market in APAC - Market size and forecast 2017-2022 ($ bn)
Exhibit 37:Medical marijuana market in APAC - Year over year growth 2018-2022 (%)
Exhibit 38:Top three countries in APAC
Exhibit 39:Market opportunity
Exhibit 40:Various diseases and associated symptoms improved by cannabis
Exhibit 41:List of approved medications containing medical marijuana
Exhibit 42:Approximate NIH funding for cannabinoid research ($ millions)
Exhibit 43:Digital engagement of some vendors through Twitter
Exhibit 44:Vendor landscape
Exhibit 45:Landscape disruption
Exhibit 46:Vendors covered
Exhibit 47:Vendor classification
Exhibit 48:Market positioning of vendors
Exhibit 49:Vendor overview
Exhibit 50:Aurora Cannabis - Business segments
Exhibit 51:Aurora Cannabis - Organizational developments
Exhibit 52:Aurora Cannabis - Geographic focus
Exhibit 53:Aurora Cannabis - Segment focus
Exhibit 54:Aurora Cannabis - Key offerings
Exhibit 55:Vendor overview
Exhibit 56:GW Pharmaceuticals - Business segments
Exhibit 57:GW Pharmaceuticals - Organizational developments
Exhibit 58:GW Pharmaceuticals - Geographic focus
Exhibit 59:GW Pharmaceuticals - Segment focus
Exhibit 60:GW pharmaceuticals - Key offerings
Exhibit 61:Vendor overview
Exhibit 62:mCig - Business segments
Exhibit 63:mCig - Organizational developments
Exhibit 64:mCig - Geographic focus
Exhibit 65:mCig - Segment focus
Exhibit 66:mCig - Key offering
Exhibit 67:Vendor overview
Exhibit 68:Medical Marijuana - Business segments
Exhibit 69:Medical Marijuana - Organizational developments
Exhibit 70:Medical Marijuana - Geographic focus
Exhibit 71:Medical Marijuana - Segment focus
Exhibit 72:Medical Marijuana - Key offering
Exhibit 73:United Cannabis overview
Exhibit 74:United Cannabis - Business segments
Exhibit 75:United Cannabis - Organizational developments
Exhibit 76:United Cannabis - Geographic focus
Exhibit 77:United Cannabis - Segment focus
Exhibit 78:United Cannabis - Key offerings

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る